Gossamer Bio Inc GOSS Fundamentals and Key Ratios

Home
Investing
Stocks
USA
NASDAQ
Gossamer Bio Inc (GOSS)
Gossamer Bio Inc (GOSS) Financials

Gossamer Bio Inc. (GOSS) Fundamentals


Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

SHARE INFORMATION
Market Cap	$ 120,259,560
Shares Outstanding	95,444,095
Float	74,250,000
Percent Float	77.79%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.00
Latest Fiscal Revenue	$ 0
Latest Fiscal EPS	$ -0.52
Latest Fiscal Date	2023-03-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	-
Dividend Rate	$ 0.00
Dividend Yield	0.0%
Payment Cash	-

HOLDERS
Institutions	354
Institutional Holdings Date	2023-03-31
Institutional Bought Previous 3 Months	60,566,778
Institutional Holdings Percent	23.5%
Institutional Sold Previous 3 Months	40,397,828
Insider Holdings Date	2023-03-31
Insider Bought Previous 3 Months	947,072
Insider Holdings Percent	5.2
Insider Sold Previous 3 Months	21,156
Insider Shares Owned	4,928,777

TRADING INFO
52 Week High	$ 15.20
52 Week Low	$ 0.91
52 Week High Change	$ -82.74
21 Day Moving Average	$ 1.3076
21 Day Extended Moving Average	$ 1.2848
50 Day Moving Average	$ 1.2339
50 Day Extended Moving Average	$ 1.3792
200 Day Moving Average	$ 5.3693
200 Day Extended Moving Average	$ 4.1013
10 Day Average Volume	2,193,468
20 Day Average Volume	2,080,369
30 Day Average Volume	1,790,930
50 Day Average Volume	1,929,698
Alpha	-0.037970
Beta	1.1988
Standard Deviation	0.201786
R2	0.104163
7 Day Price Change	$ 0.03
7 Day Percent Change	2.44%
21 Day Price Change	$ -0.16
21 Day Percent Change	-11.27%
30 Day Price Change	$ -0.10
30 Day Percent Change	-7.35%
Month to Date Price Change	$ -0.08
Month to Date Percent Change	-5.97%
Quarter to Date Price Change	$ 0.00
Quarter to Date Percent Change	0.0%
180 Day Price Change	$ -0.89
180 Day Percent Change	-41.4%
200 Day Price Change	$ -7.88
200 Day Percent Change	-86.21%
Year to Date Price Change	$ -0.91
Year to Date Percent Change	-41.94%

Gossamer Bio Inc. (GOSS) Key Ratios

PROFITABILITY
EBIT Margin	0.0%
EBITDA Margin	0.0%
Pre-Tax Profit Margin	0.0%
Profit Margin Count	0.0%
Gross Margin	0.0%
Profit Margin TOT	0.0%

INCOME STATEMENTS
Revenue	$ 0
Revenue Per Share	$ 0.00
Revenue (3 Years)	$ 0.00
Revenue (5 Years)	$ 0.00

FINANCIAL STRENGTH
Price to Tangible Book	-4.20
Total Debt To Equity	0.00
Int Coverage	0.00
Current Ratio	5.20
Leverage Ratio	0.00
Quick Ratio	5.00
Long Term Debt To Capital	0.00

VALUATION MEASURES
PE Ratio	0.00
Enterprise Value	$ -62,889,645
Price to Sales	0.00
Price to Free Cash	0.00
PE High Last 5 Years	0.00
Price To Book	-4.20
Price To Cash Flow	-0.60
PE Low Last 5 Years	0.00
Price to Tangible Book	-4.20

MANAGEMENT EFFECTIVENESS
Receivables Turnover	0.00
Invoice Turnover	0.00
Assets Turnover	0.00
Return Assets	-85.80
Return on Equity	-25,925.78
Return on Capital	0.00

Gossamer Bio Inc. (GOSS) Profile

PROFILE INFO
Issue Type	CS
SEC Type	-
Auditor	-
CEO	Faheem Hasnain
Employees	185
Last Audit	-
CIK	0001728117
Industry	Biotechnology
Sector	Healthcare
NAICS	Pharmaceutical Preparation Manufacturing(325412)

CONTACT INFO
Address	3013 Science Park Road,Suite 200 Suite 200 San Diego, CA 92121
Website	https://www.gossamerbio.com
Facsimile	-
Telephone	+1 858 684-1300
Email	-

Boards:

Quotes:

GOSS

Gossamer Bio Inc